Arterial spin labeling versus bolus-tracking perfusion in hyperacute stroke

Stroke

Volumn 45, Issue 1, 2014, Pages 127-133

  Bivard, Andrew ^a   Krishnamurthy, Venkatesh ^b   Stanwell, Peter ^c   Levi, Christopher ^b   Spratt, Neil J ^b   Davis, Stephen ^a   Parsons, Mark ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Hunter New England Health ^*  (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Perfusion imaging; Reperfusion; Stroke

Indexed keywords

EID: 84893717483     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003218     Document Type: Article

References (25)

1. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, et al; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30:1214-1225.
2. Bivard A, Spratt N, Levi CR, Parsons MW. Acute stroke thrombolysis: time to dispense with the clock and move to tissue-based decision making? Expert Rev Cardiovasc Ther. 2011;9:451-461.
3. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
4. Obach V, Oleaga L, Urra X, Macho J, Amaro S, Capurro S, et al. Multimodal CT-assisted thrombolysis in patients with acute stroke: a cohort study. Stroke. 2011;42:1129-1131.
5. Marckmann P, Skov L, Rossen K, Thomsen HS. Clinical manifestation of gadodiamide-related nephrogenic systemic fibrosis. Clin Nephrol. 2008;69:161-168.
6. Bardin T, Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol. 2010;22:54-58.
7. Wolf RL, Detre JA. Clinical neuroimaging using arterial spinlabeled perfusion magnetic resonance imaging. Neurotherapeutics. 2007;4:346-359.
8. Hernandez DA, Bokkers RP, Mirasol RV, Luby M, Henning EC, Merino JG, et al. Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke. Stroke. 2012;43:753-758.
9. Wang DJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R, et al; UCLA Stroke Investigators. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrastenhanced MRI. Stroke. 2012;43:1018-1024.
10. Menon BK, O'Brien B, Bivard A, Spratt NJ, Demchuk AM, Miteff F, et al. Assessment of leptomeningeal collaterals using dynamic CT angiography in patients with acute ischemic stroke. J Cereb Blood Flow Metab. 2013;33:365-371.
11. Parsons MW, Miteff F, Bateman GA, Spratt N, Loiselle A, Attia J, et al. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology. 2009;72:915-921.
12. Luh WM, Wong EC, Bandettini PA, Hyde JS. QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med. 1999;41:1246-1254.
13. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099-1107.
14. Barber PA, Darby DG, Desmond PM, Yang Q, Gerraty RP, Jolley D, et al. Prediction of stroke outcome with echoplanar perfusion-and diffusion-weighted MRI. Neurology. 1998;51:418-426.
15. Bivard A, Levi C, Spratt N, Parsons M. Perfusion CT in acute stroke: a comprehensive analysis of infarct and penumbra. Radiology. 2013;267:543-550.
16. Bivard A, Spratt N, Levi C, Parsons M. Perfusion computer tomography: imaging and clinical validation in acute ischaemic stroke. Brain. 2011;134(pt 11):3408-3416.
17. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke. 2010;41:34-40.
18. Raoult H, Petr J, Bannier E, Stamm A, Gauvrit JY, Barillot C, et al. Arterial spin labeling for motor activation mapping at 3T with a 32-channel coil: reproducibility and spatial accuracy in comparison with BOLD fMRI. Neuroimage. 2011;58:157-167.
19. Bivard A, Stanwell P, Levi C, Parsons M. Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke. J Neuroimaging. 2013;23:391-396.
20. Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Comparison of computed tomography perfusion and magnetic resonance imaging perfusion-diffusion mismatch in ischemic stroke. Stroke. 2012;43:2648-2653.
21. Bivard A, McElduff P, Spratt N, Levi C, Parsons M. Defining the extent of irreversible brain ischemia using perfusion computed tomography. Cerebrovasc Dis. 2011;31:238-245.
22. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
23. Ma H, Parsons MW, Christensen S, Campbell BC, Churilov L, Connelly A, et al; EXTEND investigators. A multicentre, randomized, doubleblinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke. 2012;7:74-80.
24. Zaharchuk G, El Mogy IS, Fischbein NJ, Albers GW. Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke. 2012;43:1843-1848.
25. Churilov L, Liu D, Ma H, Christensen S, Nagakane Y, Campbell B, et al. Multiattribute selection of acute stroke imaging software platform for Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) clinical trial. Int J Stroke. 2013;8:204-210.